SureTrader Advertisement Advertisement
Home > Boards > US Listed > Biotechs >

Alliqua, Inc. (ALQA)

Add ALQA Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator
Search This Board:
Last Post: 11/11/2015 9:58:50 AM - Followers: 64 - Board type: Free - Posts Today: 0

Headquartered in New York, Alliqua, Inc., (OTCBB:ALQA) is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products, utilizing its existing technology portfolio. It intends to pursue projects in the fields of active ingredient and transdermal drug delivery, as well as advanced wound care.


Alliqua's core transdermal delivery technology platform is designed to deliver drugs and other beneficial ingredients through the skin.  Transdermal delivery has multiple advantages over conventional oral and injection delivery including:

  • Avoidance of hepatic first pass metabolism causing less stress on the liver;
  • Non-invasive nature;
  • Improved patient compliance;
  • Discontinuation of administration by removal of the system;
  • Lower dosage;
  • No dependence on different metabolic rates of individuals; and
  • No interaction with the gastrointestinal system.

In addition, Alliqua's  patch technology can be utilized for the delivery of many drugs, including various proteins that have, until now, necessitated injections or intravenous infusions.

Alliqua intends to capitalize on its technology's other intrinsic benefits in various market verticals in the healthcare industry, including: wound healing, medical diagnostics and cosmeceuticals.






Alliqua, through its wholly owned subsidiary AquaMed, develops, manufactures and markets electron-beam cross-linked sheet gels for use as transdermal delivery of medication, topical application of non-prescription drugs, wound/burn dressings with and without active ingredients, components in certain medical devices, treatments, cosmetics and other commercial products.

Hydrogels are gel-like or colloidal substances made of water and solids.  They can be created chemically (through a combination of ultra violet cross-linking and chemical interface), or by mixing polymer and water, and then exposing it to an electron beam creating a "sheet" of water. Alliqua believes that its hydrogels have a competitive advantage, in part due to the following product characteristics: painless adhesion to the human body, stability of form and composition, purity, reproducibility (manufacturing high quality product on a consistent basis), compatibility with active ingredients, and high water content.

Many of the products of Alliqua's competition feature physical characteristics which Alliqua believes are less desirable than its own hydrogels

Investor relations

Alliqua Inc.
850 3rd Avenue
Suite 1801
New York, NY 10022



Subsidiary Products
Alliqua Biomedical PHN Patch
  Hydress + Plus
Aquamed Technologies Contract Manufacturing Services
  Electrode Gel
  Sheet Hydrogels
HepaLife Biosystems HepaMate®

Alliqua is currently servicing the medical components marketplace through it Aquamed Technologies, Inc. subsidiary. It is also developing finished products for commercialization under its own brand names. The following table lists the various product in commercialization and development:



Thursday, November 15, 2012

Wednesday, November 14, 2012

Tuesday, November 13, 2012

Wednesday, October 3, 2012

Wednesday, August 22, 2012

Thursday, August 16, 2012

Tuesday, August 14, 2012

Thursday, August 2, 2012

Tuesday, June 5, 2012

Thursday, May 24, 2012

CHARTS : 60 minutes - Daily - Weekly


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#4590   Insider Buying: Alliqua Biomedical CEO David Ian Johnson Giannuzzo 11/11/15 09:58:50 AM
#4589   More alerts received as of 11/06 SmartAlerts ALQA, (Trade) has Giannuzzo 11/10/15 12:53:29 AM
#4588   Who alerted it? bra1loga 11/09/15 11:46:34 PM
#4587   This is why it was hammered then, and inversor86 11/05/15 11:20:43 PM
#4586   Good buying opportunity here. Received this alert the Giannuzzo 11/05/15 02:13:59 PM
#4585   My Bad, thought I read somewhere that the Cherry_11 10/31/15 05:54:29 PM
#4584   why is that, Cherry ? bedrock 10/31/15 11:54:29 AM
#4583   Earnings are going to look rough. Cherry_11 10/29/15 07:08:46 PM
#4582   This bitch is getting hammered today starbuxsux 10/29/15 02:03:23 PM
#4581   Bought a bunch of shares this morning. Biotech ronpopeil 10/06/15 12:15:14 PM
#4580   Alliqua (ALQA) Snapshot DonShimoda 10/05/15 04:20:47 PM
#4579 Giannuzzo 08/11/15 11:14:24 AM
#4578   Alliqua BioMedical, Inc. Reports Second Quarter Financial Results nbm16yankees 08/06/15 08:26:34 AM
#4577   $ALQA - The Securities and Exchange Commission has starbuxsux 07/27/15 02:00:08 PM
#4576   Diabetes Newsletter Interview with ALQA part 2 nbm16yankees 07/21/15 08:40:43 AM
#4575   Their products are not sexy so not much ronpopeil 07/16/15 01:04:16 PM
#4574   WHY IS THE VOLUME HERE ALWAYS SO MINISCULE? starbuxsux 07/16/15 12:54:46 PM
#4573   Alliqua featured in Diabetes Newsletter nbm16yankees 07/14/15 09:11:16 AM
#4572   Alliqua BioMedical, Inc. to Announce Second Quarter of nbm16yankees 07/14/15 08:35:53 AM
#4571   Alliqua rings Nasdaq bell this morning. Good publicity!! Giannuzzo 07/06/15 10:43:34 AM
#4570   Alliqua BioMedical, Inc. to Ring the Nasdaq Stock nbm16yankees 06/29/15 06:19:51 PM
#4569   WEEEEEEEE! starbuxsux 06/26/15 09:57:21 AM
#4568   Cowen & Co Initiates coverage with $9 PT 6/26/15 nbm16yankees 06/26/15 09:41:23 AM
#4567   Alliqua BioMedical, Inc. Announces the Publication of Results nbm16yankees 06/25/15 08:29:36 AM
#4566   Thanks sbux, I've seen you on other forums, inversor86 06/16/15 11:06:56 PM
#4565   I like RBC, Northland, and HC. All inversor86 06/16/15 10:56:19 PM
#4564   RBC Capital issues $8 price target nbm16yankees 06/05/15 11:26:33 AM
#4563   Alliqua BioMedical, Inc. Appoints Nino Pionati as Chief starbuxsux 06/03/15 07:51:03 AM
#4562   H.C. Wainwright Assigned a Buy Rating to Alliqua By Giannuzzo 05/18/15 09:29:10 AM
#4561   Great numbers for ALQA! starbuxsux 05/15/15 11:26:17 AM
#4560   Insider buy just reported! Giannuzzo 05/08/15 12:54:23 PM
#4559   5 Stocks Under $10 Set to Soar (Alliqua is Giannuzzo 05/05/15 09:27:48 AM
#4558   Alliqua BioMedical, Inc. Announces Pricing of Public Offering nbm16yankees 04/29/15 09:41:04 AM
#4557   Right where expected, good. inversor86 04/23/15 01:32:34 PM
#4556   Alliqua BioMedical, Inc. Announces Preliminary First Quarter 2015 nbm16yankees 04/23/15 08:35:45 AM
#4555   Alliqua BioMedical, Inc. Receives Coverage From Medicare Administrative nbm16yankees 04/16/15 08:40:17 AM
#4554   Good news here... Giannuzzo 04/15/15 11:27:26 PM
#4553   Chardan Capital Initiates Coverage with $8 PT 4/10/15 nbm16yankees 04/10/15 09:47:15 AM
#4552   I have been adding shares of ALQA in inversor86 04/01/15 10:09:24 PM
#4551   why would Alliqua be down--after a reasonably upbeat bedrock 03/02/15 01:59:07 PM
#4550   Alliqua BioMedical, Inc. Reports Fourth Quarter and Fiscal nbm16yankees 02/24/15 10:19:34 AM
#4549   Alliqua BioMedical, Inc. to Present at Upcoming Investor Conferences nbm16yankees 02/17/15 09:41:49 AM
#4548   Alliqua Biomedical: An Attractive Opportunity In The Wound nbm16yankees 02/10/15 02:12:37 PM
#4547   alqa d TREND1 02/04/15 04:10:06 PM
#4546   alqa d TREND1 02/04/15 04:09:58 PM
#4545   Alliqua BioMedical, Inc. to Acquire Celleration, Inc. nbm16yankees 02/02/15 05:11:34 PM
#4544   Alliqua BioMedical Announces Group Purchasing Agreement With Premier, Inc. nbm16yankees 01/05/15 10:01:22 AM
#4543   $ALQA DD Notes ~ stocktrademan 11/20/14 10:04:47 AM
#4542   Anyone know why trading was halted today? nbm16yankees 10/15/14 12:07:38 PM
#4541   waiting for the 3's to get back in ontrget6 10/07/14 12:23:36 AM